Oramed Pharmaceuticals Inc. (ORMP) has 20 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は Lee James G 10,069,013 株保有. その他の主要保有者には Bronfeld Zeev および KIDRON NADAV.
過去12ヶ月間にインサイダーは 25 件の取引を実施 ORMP 株式 — 17 件の買い (評価額 $1.44K) および 0 件の売り (評価額 RSU アワード). インサイダーの買いが売りを上回っており、会社の見通しに対する自信の表れかもしれません.
ORMP インサイダー保有状況
最大保有者
Lee James G
10,069,013 株
インサイダー上位保有者
| # |
氏名 |
役職 |
保有株数 |
最終申告日 |
相対規模 |
| 1 |
Lee James G |
CEO |
10,069,013 |
2004-06-03 |
|
| 2 |
Bronfeld Zeev |
10 Percent Owner |
5,808,517 |
2011-10-05 |
|
| 3 |
Kidron Nadav |
President and CEO |
3,422,243 |
2026-03-31 |
|
| 4 |
Hexter Joshua |
COO & Cbo |
1,160,384 |
2026-03-18 |
|
| 5 |
Kidron Miriam |
Chief Scientific Officer |
1,133,138 |
2026-03-31 |
|
| 6 |
Orlev Chaime |
CFO, Treasurer and Secretary |
828,000 |
2008-10-16 |
|
| 7 |
Gabay Avraham |
Chief Financial Officer |
745,145 |
2026-03-18 |
|
| 8 |
Silberman David |
Chief Financial Officer |
366,500 |
2024-01-08 |
|
| 9 |
Li Xiaopeng |
Director |
206,350 |
2017-08-03 |
|
| 10 |
Mayer Arie |
Director |
163,109 |
2026-01-05 |
|
| 11 |
Derovan Netanel |
Chief Legal Officer |
149,500 |
2023-05-31 |
|
| 12 |
Rozov Yadin |
Director |
146,500 |
2024-01-08 |
|
| 13 |
Sank Leonard |
Director |
128,021 |
2025-06-09 |
|
| 14 |
Rabinowitz Michael |
Chief Commercial Officer |
126,143 |
2023-01-04 |
|
| 15 |
Shapiro Benjamin |
Director |
119,720 |
2026-01-05 |
|
| 16 |
Aghion Daniel |
Director |
107,191 |
2026-01-02 |
|
| 17 |
Reznick Yehuda |
Director |
98,930 |
2026-01-05 |
|
| 18 |
Rakin Kevin |
Director |
46,661 |
2022-03-22 |
|
| 19 |
Law Ronald Edward |
Chief Strategy Officer |
37,152 |
2017-03-21 |
|
| 20 |
Eisenberg Hilla |
CFO, Treasurer and Secretary |
37,000 |
2019-02-28 |
|
最近の取引 (過去12ヶ月)
| 日付 |
氏名 |
役職 |
種類 |
株数 |
株価 |
価値 |
| 2026-03-30 |
Kidron Miriam |
Chief Scientific Officer |
RSU 源泉徴収 |
435,084 |
$3.31 |
$1.44M |
| 2026-03-30 |
Kidron Nadav |
President and CEO |
RSU 源泉徴収 |
44,818 |
$3.31 |
$148.35K |
| 2026-03-17 |
Gabay Avraham |
Chief Financial Officer |
RSU 付与（制限付株式） |
95,889 |
- |
- |
| 2026-03-17 |
Hexter Joshua |
COO & Cbo |
RSU 付与（制限付株式） |
95,889 |
- |
- |
| 2026-03-17 |
Kidron Miriam |
Chief Scientific Officer |
RSU 付与（制限付株式） |
119,558 |
- |
- |
| 2026-03-17 |
Kidron Nadav |
President and CEO |
RSU 付与（制限付株式） |
167,005 |
- |
- |
| 2026-03-12 |
Kidron Nadav |
President and CEO |
贈与（送付） |
100,000 |
- |
- |
| 2026-01-22 |
Gabay Avraham |
Chief Financial Officer |
オプション行使（売却） |
19,000 |
- |
- |
| 2026-01-22 |
Hexter Joshua |
COO & Cbo |
オプション行使（売却） |
19,000 |
- |
- |
| 2026-01-22 |
Kidron Miriam |
Chief Scientific Officer |
オプション行使（売却） |
19,000 |
- |
- |
| 2026-01-22 |
Kidron Nadav |
President and CEO |
オプション行使（売却） |
109,000 |
- |
- |
| 2026-01-14 |
Kidron Miriam |
Chief Scientific Officer |
贈与（送付） |
86,166 |
- |
- |
| 2025-12-31 |
Reznick Yehuda |
Director |
RSU 付与（制限付株式） |
30,000 |
$0.01 |
$360.00 |
| 2025-12-31 |
Shapiro Benjamin |
Director |
RSU 付与（制限付株式） |
30,000 |
$0.01 |
$360.00 |
| 2025-12-31 |
Mayer Arie |
Director |
RSU 付与（制限付株式） |
30,000 |
$0.01 |
$360.00 |
| 2025-12-31 |
Hexter Joshua |
COO & Cbo |
RSU 付与（制限付株式） |
19,000 |
- |
- |
| 2025-12-31 |
Kidron Miriam |
Chief Scientific Officer |
RSU 付与（制限付株式） |
19,000 |
- |
- |
| 2025-12-31 |
Kidron Nadav |
President and CEO |
RSU 付与（制限付株式） |
109,000 |
- |
- |
| 2025-12-31 |
Aghion Daniel |
Director |
RSU 付与（制限付株式） |
30,000 |
$0.01 |
$360.00 |
| 2025-12-31 |
Gabay Avraham |
Chief Financial Officer |
RSU 付与（制限付株式） |
19,000 |
- |
- |
| 2025-06-05 |
Reznick Yehuda |
Director |
RSU 付与（制限付株式） |
30,000 |
- |
- |
| 2025-06-05 |
Aghion Daniel |
Director |
RSU 付与（制限付株式） |
30,000 |
- |
- |
| 2025-06-05 |
Shapiro Benjamin |
Director |
RSU 付与（制限付株式） |
30,000 |
- |
- |
| 2025-06-05 |
Mayer Arie |
Director |
RSU 付与（制限付株式） |
30,000 |
- |
- |
| 2025-06-05 |
Sank Leonard |
Director |
RSU 付与（制限付株式） |
30,000 |
- |
- |
